Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 1, Pages 55-66
Publisher
Informa Healthcare
Online
2013-12-06
DOI
10.1517/13543784.2013.839658
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis
- (2013) A. Straumann et al. ALLERGY
- 2-(1H-Pyrazol-4-yl)acetic acids as CRTh2 antagonists
- (2013) Miriam Andrés et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibition of antigen-induced airway inflammation and hyperresponsiveness in guinea pigs by a selective antagonist of “chemoattractant receptor homologous molecule expressed on Th2 cells” (CRTH2)
- (2013) Mamoru Tasaki et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Identification of 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic Acid (Setipiprant/ACT-129968), a Potent, Selective, and Orally Bioavailable Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2) Antagonist
- (2013) Heinz Fretz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Evolution of novel tricyclic CRTh2 receptor antagonists from a (E)-2-cyano-3-(1H-indol-3-yl)acrylamide scaffold
- (2012) Anja Valdenaire et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Biochemical and pharmacological characterization of AZD1981, an orally available selective DP2antagonist in clinical development for asthma
- (2012) JA Schmidt et al. BRITISH JOURNAL OF PHARMACOLOGY
- UGT2B17 Genetic Polymorphisms Dramatically Affect the Pharmacokinetics of MK-7246 in Healthy Subjects in a First-in-Human Study
- (2012) Y-H Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459
- (2012) D. Singh et al. EUROPEAN RESPIRATORY JOURNAL
- Novel prostaglandin receptor modulators: a patent review (2002 – 2012) – part I: non-EP receptor modulators
- (2012) Christina Lamers et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients
- (2012) William W. Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Update on the Development of Antagonists of Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2). From Lead Optimization to Clinical Proof-of-Concept in Asthma and Allergic Rhinitis
- (2012) Roy Pettipher et al. JOURNAL OF MEDICINAL CHEMISTRY
- CRTH2 Antagonist MK-7246: A Synthetic Evolution from Discovery through Development
- (2012) Carmela Molinaro et al. JOURNAL OF ORGANIC CHEMISTRY
- T cell homing to epithelial barriers in allergic disease
- (2012) Sabina A Islam et al. NATURE MEDICINE
- Development of a Practical and Scalable Synthesis of a Potent CRTH2 Antagonist
- (2012) Shinya Yoshida et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Discovery of novel and potent CRTH2 antagonists
- (2011) Shinji Ito et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Optimization of phenylacetic acid derivatives for CRTH2 and DP selective antagonism
- (2011) Yingcai Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma
- (2011) N. Barnes et al. CLINICAL AND EXPERIMENTAL ALLERGY
- A novel DP2receptor antagonist (AM-461): a patent evaluation of WO2011085033
- (2011) Peter Norman EXPERT OPINION ON THERAPEUTIC PATENTS
- Pharmacodynamics, Pharmacokinetics, and Safety of AM211: A Novel and Potent Antagonist of the Prostaglandin D2Receptor Type 2
- (2011) G. Bain et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacology of AM211, a Potent and Selective Prostaglandin D2 Receptor Type 2 Antagonist That Is Active in Animal Models of Allergic Inflammation
- (2011) G. Bain et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
- (2011) D. F. Woodward et al. PHARMACOLOGICAL REVIEWS
- Exploration of SAR features by modifications of thiazoleacetic acids as CRTH2 antagonists
- (2010) Marie Grimstrup et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Azaindoles as potent CRTH2 receptor antagonists
- (2010) Daniel Simard et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases
- (2010) Michel Gallant et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- DP2receptor antagonists in development
- (2010) Peter Norman EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
- (2010) F. G. Gervais et al. MOLECULAR PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now